THE OXIDATIVE METABOLISM DISORDERS IN PATIENTS SUFFERING FROM TYPE II DIABETES MELLITUS AND DISEASES OF THE RESPIRATORY APPARATUS
https://doi.org/10.25207/1608-6228-2017-1-7-11
Abstract
In the present research the changes in the enzyme link of the antioxidative system as well as in the content of reduced erythrocyte glutathione and the oral liquid in patients suffering from type II diabetes mellitus, bronchial asthma, chronic obstructive lungs disorder and comorbidities of the researched diseases have been disclosed. The regularities in changes of the biochemical indices on the systemic and the local level have been revealed. As a rule in patients suffering from the pathology comorbidities the more apparent metabolic disorders have been indicated. The most essential changes in the erythrocyte suspension have been revealed in patients suffering from all the pathologies found three. The activity of superoxide dismutase has increased by 29 %, of catalase by 65 %, of glutathione reductase by 2,4 times while the activity of glutathione peroxidase has decreased by 3,3 times. The glutathione concentration in the same patient group has been 19 % down from the control indices. In the oral liquid of the same group the activity of superoxide dismutase as well as the one of glutathione reductase has increased by 81 % and 83 % respectively. The activity of glutathione peroxidase has not changed, the activity of catalase has decreased by 9,2 times. In general, the indices of patients suffering from the comorbidities have been closer to the pathologies of the respiratory system which proves the conception of the leading role of oxidative disorders in such patients.
About the Authors
E. A. ALEKSEENKO
Kuban State Medical University
Russian Federation
Department of fundamental and clinical biochemistry
Russian Federation
Department of fundamental and clinical biochemistry
I. M. BYKOV
Kuban State Medical University
Russian Federation
Department of fundamental and clinical biochemistry
Russian Federation
Department of fundamental and clinical biochemistry
I. A. LUKONIN
The Budgetary Institution of Public Health Care «The Municipal Clinical Hospital № 1»
Russian Federation
Russian Federation
Russia, 350063, Krasnodar, Sedin’ Street, 4; tel. 8 (918) 212-55-30
References
1. Алексеенко Е. А., Попов К. А., Быков И. М., Сепиашвили Р. И. Метаболические изменения биохимических показателей на местном и системном уровнях у пациентов с аллергическими заболеваниями // Аллергология и иммунология. – 2016. – Т. 17, № 2. – С. 93–97.
2. Болевич С. Б. Бронхиальная астма и свободнорадикальные процессы: патогенетические, клинические и терапевтические аспекты. – Москва, 2006. – 253 с.
3. Карпищенко А. И. Медицинские лабораторные технологии. Справочник. – СПб.: Интермедика, 2002. – 600 с.
4. Костюк В. А., Потапович А. И., Ковалева Ж. И. Простой и чувствительный метод определения супероксиддисмутазы, основанный на реакции окисления кверцитина // Вопросы медицинской химии. – 1990. – № 2. – С. 88–91.
5. Лазуткина Е. Л., Музыченко Л. М., Ландышев Ю. С., Цырендоржиев Д. Д., Лазаренко Л. Л. Особенности про- и антиоксидантного статуса сыворотки крови больных бронхиальной астмой при разных вариантах сенсибилизации // Бюллетень физиологии и патологии дыхания. – 2014. – № 51. – С. 15–19.
6. Мелконян К. И., Попов К. А., Литвинова М. Г., Карташевская М. И. Изменение антиокислительной активности плазмы крови и возможности антиоксидантной коррекции у больных с сочетанным течением псориаза и сахарного диабета // Фундаментальные исследования. – 2015. – № 1–4. – С. 774–778.
7. Соодаева С. К. Окислительный стресс и антиоксидантная терапия при заболеваниях органов дыхания // Пульмонология. – 2006. – № 5. – С. 122–126.
8. Цымбалюк И. Ю., Попов К. А., Мелконян К. И., Сторожук А. П. Изменения в системе глутатиона при интраоперационной ишемии печени у крыс // Современные проблемы науки и образования. – 2015. – № 5. – С. 81.
9. Basov A. A., Akopova V. A., Bykov I. M. Changing the parameters of prooxidant- antioxidant system in blood and oral fluid of patients with ischemic heart disease and type 2 diabetes mellitus // International Journal on Immunorehabilitation. – 2013. – Т. 15, № 2. – С. 84–86.
10. Bykova N., Basov A., Melkonyan K., Alekseenko E.,Popov K., Bykov I. NON-Invasive monitoring for local immune and antioxidant resistance in patients with ischemic heart disease and type 2 diabetes // Медицинский вестник Северного Кавказа. – 2016. – Т. 11, № 2. – С. 147–149.
11. Dozor A. J. The role of oxidative stress in the pathogenesis and treatment of asthma // Ann. N. Y. Acad. Sci. – 2010. – Vоl. 1203. – Р. 133–137.
12. Graham J. Burton, Eric Jauniaux. Oxidative stress // Best Pract. Res. Clin. Obstet Gynaecol. – 2011. – Vol 25, № 3. – Р. 287–299.
13. You Sook Cho, Hee-Bom Moon. The role of oxidative stress in the pathogenesis of asthma // Allergy Asthma Immunol. Res. – 2010. – № 2. – Р. 183–187.
Review
For citations:
ALEKSEENKO E.A., BYKOV I.M., LUKONIN I.A. THE OXIDATIVE METABOLISM DISORDERS IN PATIENTS SUFFERING FROM TYPE II DIABETES MELLITUS AND DISEASES OF THE RESPIRATORY APPARATUS. Kuban Scientific Medical Bulletin. 2017;1(1):7-11. (In Russ.) https://doi.org/10.25207/1608-6228-2017-1-7-11
Views:
682
Email this article 